High-Intensity Interval Training Reduces Liver Enzyme Levels and Improves MASLD-Related Biomarkers in Overweight/Obese Girls.

Wissal Abassi, Nidhal Jebabli, Nejmeddine Ouerghi, Anissa Bouassida, Katja Weiss, Beat Knechtle, Moncef Feki, Mohamed Bessem Hammami

Journal: Nutrients 2025;17(1):

PMID: 39796598

Plain Language Summary

plain language summary logo

Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterised by build up of fats in the liver in the absence of alcohol. Diet and lifestyle changes are key to its management. However, time constraints in young people mean that time-efficient ways of exercising need to be prioritised. High intensity interval training (HIIT) is a time-efficient aerobic exercise that may benefit those with MASLD, however few studies exist. This randomised controlled trial of 33 adolescent girls with overweight/obesity aimed to determine the impact of high-intensity interval training (HIIT) on liver health. Participants were divided into two groups: one group engaged in a nine-week HIIT programme, while the other group did not participate in any exercise intervention.

The results showed that the girls who took part in the HIIT programme had reduced levels of liver enzymes and improved markers related to MASLD. Improvements were seen in systolic blood pressure, plasma lipids, and blood sugar. Fitness was also seen to improve.

It was concluded that HIIT may be beneficial for improving liver health in this population. This study could be used by healthcare professionals to understand how high-intensity interval training can positively affect liver health in overweight and obese adolescent girls. Although dietary changes were not required to see benefits, diet optimisation may have synergistic effects.

Expert Review

Reviewer: Sarah Cassar
26th Sep 2025
plain language summary logo

Conflict of interest

None

Take home message

  • Short-term HIIT programmes may provide measurable benefits for overweight/obese adolescents, particularly in body composition and metabolic markers.

  • Improvements in liver enzymes and lipids observed in this trial suggest that HIIT could play a supportive role in MASLD management.

  • Structured exercise interventions in adolescence might help reduce longer-term risk of cardiometabolic complications.

Evidence category

A: Meta-analyses, position-stands, randomized-controlled trials (RCTs)

Summary review

Introduction

Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterised by the presence of hepatic steatosis with the onset of metabolic risk factors. This study aimed to evaluate the effects of high-intensity interval training (HIIT) on selected MASLD-related biomarkers in adolescents with overweight/obesity.

Methods

This was a nine-week randomised controlled trial that enrolled thirty-six girls who were randomly assigned to the training (n = 18) or control (n = 18) groups. Girls in the control group continued their regular physical education classes but did not participate in additional training programmes.

Results

  • At baseline, there were no significant differences between groups.

  • Anthropometric and physical outcomes (HIIT group): Significant improvements were observed in body mass (p < .001; ES = 0.25), BMI (p = .001; ES = 0.29), body fat (p < .001; ES = 0.52), waist circumference (p = .003; ES = 0.37), and systolic blood pressure (p = .011; ES = 0.80). Maximal aerobic speed increased (p = .035; ES = 0.54) and maximal heart rate improved (p = .035; ES = 0.73). No changes occurred in the control group.

  • Between-group comparisons: The HIIT group demonstrated higher maximal aerobic speed (p = .010; ES = 0.99, large effect) and lower maximal heart rate (p < .001; ES = 1.40, large effect) versus controls.

  • Biochemical outcomes (HIIT group): Significant reductions occurred in total cholesterol (p = .003; ES = 0.45), triglycerides (p = .005; ES = 0.54), low-density lipoprotein cholesterol (p = .002; ES = 0.60), alanine transaminase (p = .013; ES = 0.47), aspartate aminotransferase (AST) (p = .012; ES = 0.58), and HOMA-IR (p = .010; ES = 0.47). High-density lipoprotein cholesterol increased (p = .013; ES = 0.36).

  • Between-group comparisons: AST was significantly lower in the HIIT group (p = .036; ES = 0.79, moderate effect).

Conclusion

The authors concluded that a nine-week HIIT programme improves body composition and reduces liver enzymes, plasma lipids, blood pressure, and insulin resistance in over-weight/obese adolescent girls.

Clinical practice applications

  • HIIT can be considered as a structured, evidence-based exercise plan alongside dietary and lifestyle interventions for overweight/obese adolescents with MASLD.

  • Incorporating short HIIT sessions may be more acceptable and feasible for young people compared to longer exercise regimens.

  • Improvements in liver enzymes, blood pressure, lipids and insulin resistance highlight the importance of integrating physical activity into MASLD management plans.

Considerations for future research

  • Further research is needed to clarify the mechanisms underlying the effects of HIIT on fatty liver while focusing on the potential direct action of muscle metabolism on the liver.

  • Future research should include larger, more diverse populations and both sexes to explore gender differences.

  • Studies should also control for diet and energy intake, monitor adherence to HIIT, and assess pubertal hormones that may affect outcomes.

plain language summary logo
Expert reviews are written by nutrition professionals and academics with advanced qualifications to provide a critical appraisal of the article and implications for practice. Each review is peer-reviewed by a member of the NED Editorial Board. Find out more about our NED Expert Reviewers here.

Abstract

BACKGROUND/OBJECTIVES

Despite the abundant body of evidence linking high-intensity interval training (HIIT) to cardiometabolic markers, little is known about how HIIT affects liver enzymes, particularly in obese adolescents. This study aimed to investigate the effects of HIIT on metabolic dysfunction-associated steatotic liver disease (MASLD)-related biomarkers in overweight/obese adolescent girls.

METHODS

Thirty-three overweight/obese adolescent girls (age, 17.0 ± 1.15 yr.; body mass index, 33.3 ± 4.77 kg/m) were randomly assigned to HIIT ( = 17) or control ( = 16) groups. The HIIT group participated in a nine-week HIIT program (three times weekly) without caloric restriction. Maximal aerobic speed, body composition indexes, blood pressure, MASLD-related biomarkers [liver enzymes (alanine aminotransferase (ALT) and aspartate aminotransferase (AST)), plasma lipids, uric acid, platelet count, and homeostasis model assessment index for insulin-resistance (HOMA-IR)] were examined at baseline and after the intervention.

RESULTS

Significant "time × group" interactions were found for body composition indexes, systolic blood pressure, maximal aerobic speed, liver enzymes ALT and AST, plasma lipids, glucose, and HOMA-IR. The HIIT program resulted in an increase in maximal aerobic speed ( = 0.035) and a decrease in body composition and plasma lipids ( < 0.01), systolic blood pressure ( = 0.011), ALT ( = 0.013), AST ( = 0.012), and HOMA-IR ( = 0.01), but no significant changes in uric acid and platelet count. None of these markers changed in the control group.

CONCLUSIONS

HIIT resulted in an improvement in MASLD-related biomarkers. HIIT could be an effective exercise therapy to prevent and reverse MASLD in adolescents with obesity.

Address: Research Unit "Sport Sciences, Health and Movement" (UR22JS01), High Institute of Sport and Physical Education of Kef, University of Jendouba, Kef 7100, Tunisia.; Research Unit "Sport Sciences, Health and Movement" (UR22JS01), High Institute of Sport and Physical Education of Kef, University of Jendouba, Kef 7100, Tunisia.; Faculty of Medicine of Tunis, Rabta Hospital, LR99ES11, University of Tunis El Manar, Tunis 1007, Tunisia.; High Institute of Sport and Physical Education of Gafsa, University of Gafsa, Gafsa 2100, Tunisia.; Faculty of Medicine of Tunis, Rabta Hospital, LR99ES11, University of Tunis El Manar, Tunis 1007, Tunisia.; Institute of Primary Care, University of Zurich, 8091 Zurich, Switzerland.; Institute of Primary Care, University of Zurich, 8091 Zurich, Switzerland.; Medbase St. Gallen Am Vadianplatz, 9000 St. Gallen, Switzerland.

Patient Centred Factor

Laboratory Testing

Modifiable Lifestyle Factors

Jadad Score

Allocation Concealment

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.